Citable company snapshot
Medtronic's latest SEC-sourced 2026-01-23 period shows $9.02B in revenue and $1.14B in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| xbrl:RevenueFromContractWithCustomerExcludingAssessedTax | Jan 23, 2026 | $9.02B | $8.96B | +0.6% |
| xbrl:GrossProfit | Apr 24, 2020 | $3.73B | $5.32B | -29.8% |
| xbrl:OperatingIncomeLoss | Jan 23, 2026 | $1.46B | $1.69B | -13.2% |
| xbrl:NetIncomeLoss | Jan 23, 2026 | $1.14B | $1.37B | -16.8% |
| standalone via YTD differencing | Jan 23, 2026 | $2.74B | $925.00M | +196.6% |
| Free Cash Flow (computed) | Jan 23, 2026 | $2.30B | $457.00M | +403.3% |
Source: SEC EDGAR XBRL; period Jan 23, 2026; filed Feb 24, 2026; accession 0001628280-26-011107.
Continue research
Follow same-sector companies and source explainers connected to the financials view.
A factual guide to free cash flow — how it is built from the cash flow statement, why presentations differ, and how Aerarium Research shows the source.
A factual guide to working capital, current assets, current liabilities, and the operating cash cycle.
A factual guide to stock-based compensation, how it appears in company filings, and why it connects cash flow to share count.
A factual guide to goodwill, intangible assets, acquisitions, and impairment charges in company financial statements.
